UlasDardaBayraktarMD

PubMed

• 9 citations
  Prognostic Index for Critically Ill Allogeneic Transplantation Patients
  Ulas D. Bayraktar, Denái R. Milton, Elizabeth J. Shpall, Gabriela Rondon, Kristen Price, Richard E. Champlin, Joseph L. Nates> ;Biology of Blood and Marrow Transplantation. 2017 Jun 1
• 19 citations
  Optimal Threshold and Time of Absolute Lymphocyte Count Assessment for Outcome Prediction after Bone Marrow Transplantation
  Ulas D. Bayraktar, Denái R. Milton, Michele Guindani, Gabriela Rondon, Julianne Chen, Gheath Alatrash, Katayoun Rezvani, Richard E. Champlin, Stefan O. Ciurea> ;Biology of Blood and Marrow Transplantation. 2016 Mar 1
• 20 citations
  Intensive care outcomes in adult hematopoietic stem cell transplantation patients.
  Ulas D. Bayraktar, Joseph L. Nates> ;World Journal of Clinical Oncology. 2016 Feb 10
• 35 citations
  “No donor”? Consider a haploidentical transplant
  Stefan O. Ciurea, Ulas D. Bayraktar> ;Blood Reviews. 2015 Mar 1
• 14 citations
  Zidovudine-based lytic-inducing chemotherapy for Epstein–Barr virus-related lymphomas
  Ulas Darda Bayraktar, Luis Diaz, Brittany Ashlock, Ngoc L. Toomey, Lisa Cabral, Soley Bayraktar, Denise Pereira, Dirk P. Dittmer, Juan Carlos Ramos> ;Leukemia & Lymphoma. 2014 Jan 1
• Strategies in Haploidentical Stem Cell Transplantation in Adults.
  Bayraktar, U. D.,Ciurea, S. O.> ;Turk J Haematol. 2014 Jan 05
• 50 citations
  Hematopoietic Cell Transplantation–Specific Comorbidity Index Predicts Inpatient Mortality and Survival in Patients Who Received Allogeneic Transplantation Admitted to...
  Ulas D. Bayraktar, Elizabeth J. Shpall, Ping Liu, Stefan O. Ciurea, Gabriela Rondon, Marcos de Lima, Marylou Cardenas-Turanzas, Kristen Price, Richard E. Champlin, Jos...> ;Journal of Clinical Oncology. 2013 Nov 20
• 7 citations
  Comparison of cancer care and outcomes between a public safety-net hospital and a private cancer center
  Ulas Darda Bayraktar, Sean Warsch, Emerson Y. Chen, Caio Max S. Rocha Lima, Denise Pereira> ;Journal of Health Care for the Poor and Underserved. 2013 Aug 1
• 73 citations
  Ex vivo T cell-depleted versus unmodified allografts in patients with acute myeloid leukemia in first complete remission.
  Ulas D. Bayraktar, Marcos de Lima, Rima M. Saliba, Molly Maloy, Hugo Castro-Malaspina, Julianne Chen, Gabriela Rondon, Alexander Chiattone, Ann A. Jakubowski, Farid Bo...> ;Biology of Blood and Marrow Transplantation. 2013 Jun 1
• 78 citations
  Fifty Years of Melphalan Use in Hematopoietic Stem Cell Transplantation
  Ulas D. Bayraktar, Qaiser Bashir, Muzaffar H. Qazilbash, Richard E. Champlin, Stefan O. Ciurea> ;Biology of Blood and Marrow Transplantation. 2013 Mar 1
• 183 citations
  Improved Early Outcomes Using a T Cell Replete Graft Compared with T Cell Depleted Haploidentical Hematopoietic Stem Cell Transplantation
  Stefan O. Ciurea, Victor E. Mulanovich, Rima M. Saliba, Ulas D. Bayraktar, Ying Jiang, Roland L. Bassett, Sa Wang, Marina Konopleva, Marcelo Fernandez-Vina, Nivia Mont...> ;Biology of Blood and Marrow Transplantation. 2012 Dec 1
• 3 citations
  Successful treatment of anal gland adenocarcinoma with combined modality therapy.
  Sean Warsch, Ulas D. Bayraktar, B-Chen Wen, Joseph Zeitouni, Floriano Marchetti, Caio Rocha-Lima, Alberto J. Montero> ;Gastrointestinal Cancer Research. 2012 Mar 1
• 17 citations
  Outcome of patients with relapsed/refractory acquired immune deficiency syndrome-related lymphoma diagnosed 1999-2008 and treated with curative intent in the AIDS Mali...
  Ulas Darda Bayraktar, Juan Carlos Ramos, Adam M. Petrich, Neel K. Gupta, Shelly Lensing, Page C. Moore, Erin Reid, David M. Aboulafia, Lee Ratner, Ronald T. Mitsuyasu,...> ;Leukemia & Lymphoma. 2012 May 29
• 27 citations
  Vitamin D receptor upregulation in alloreactive human T cells.
  Richard W. Joseph, Ulas Darda Bayraktar, Tae Kon Kim, Lisa S. St. John, Uday R. Popat, Jahan Khalili, Jeffrey J. Molldrem, Eric D. Wieder, Krishna V. Komanduri> ;Human Immunology. 2012 Jul 1
• 26 citations
  Progress in haploidentical stem cell transplantation.
  Ulas D. Bayraktar, Richard E. Champlin, Stefan O. Ciurea> ;Biology of Blood and Marrow Transplantation. 2012 Mar 1
• 76 citations
  Treatment of FLT3-ITD-Positive Acute Myeloid Leukemia Relapsing after Allogeneic Stem Cell Transplantation with Sorafenib
  Manish Sharma, Farhad Ravandi, Ulas D. Bayraktar, Alexandre Chiattone, Qaiser Bashir, Sergio Giralt, Julianne Chen, Muzaffar H. Qazilbash, Partow Kebriaei, Marina Kono...> ;Biology of Blood and Marrow Transplantation. 2011 Dec 1
• 8 citations
  Preoperative docetaxel/cisplatin/5-fluorouracil chemotherapy in patients with locally advanced gastro-esophageal adenocarcinoma.
  Ulas Darda Bayraktar, Soley Bayraktar, Peter J. Hosein, Emerson Y. Chen, Leonidas G. Koniaris, Caio Rocha-Lima, Alberto J. Montero> ;Medical Oncology. 2012 Sep 1
• 58 citations
  Does delay of adjuvant chemotherapy impact survival in patients with resected stage II and III colon adenocarcinoma
  Ulas Darda Bayraktar, Emerson Y. Chen, Soley Bayraktar, Laurence R. Sands, Floriano Marchetti, Alberto J. Montero, Caio Rocha-Lima> ;Cancer. 2011 Jun 1
• 3 citations
  Simultaneous measurement of ERα, HER2, and PhosphoERK1/2 in breast cancer cell lines by flow cytometry
  Ulas Darda Bayraktar, Tae Kon Kim, Katherine Drews-Elger, Cara L. Benjamin, Dorraya El-Ashry, Eric D. Wieder, Krishna V. Komanduri> ;Breast Cancer Research and Treatment. 2011 May 24
• 9 citations
  Azacitidine combined with gemtuzumab ozogamicin in patients with relapsed/refractory acute myeloid leukemia.
  Ulas Darda Bayraktar, Gelenis Domingo, Jessica Schmit, Denise Pereira> ;Leukemia & Lymphoma. 2011 Apr 19
• 8 citations
  High-dose glucocorticoids improve renal failure reversibility in patients with newly diagnosed multiple myeloma
  Ulas Darda Bayraktar, Sean Warsch, Denise Pereira> ;American Journal of Hematology. 2011 Feb 1
• 6 citations
  Advances in haploidentical stem cell transplantation
  Ulas D. Bayraktar, Marcos de Lima, Stefan O. Ciurea> ;Revista Brasileira De Hematologia e Hemoterapia. 2011 Jan 1
• 56 citations
  Primary CNS lymphoma in HIV positive and negative patients: comparison of clinical characteristics, outcome and prognostic factors
  Soley Bayraktar, Ulas Darda Bayraktar, Juan Carlos Ramos, Alexandra Stefanovic, Izidore S. Lossos> ;Journal of Neuro-Oncology. 2011 Jan 1
• 51 citations
  Primary ocular adnexal mucosa-associated lymphoid tissue lymphoma (MALT): single institution experience in a large cohort of patients
  Soley Bayraktar, Ulas Darda Bayraktar, Alexandra Stefanovic, Izidore S. Lossos> ;British Journal of Haematology. 2011 Jan 1
• Does delay of adjuvant chemotherapy impact survival in patients with resected stage II and III colon adenocarcinoma?
  Bayraktar, U.D., Chen, E., Bayraktar, S., Sands, L.R., Marchetti, F., Montero, A.J., Rocha-Lima, C.S.> ;Cancer. 2010 Dec 17
• Join now to see all

Journal Articles

• The role of tyrosine kinase inhibitors in the treatment of advanced hepatocellular carcinoma.  
  Bayraktar UD, Journal of Hepato-Gastroenterology

Books/Book Chapters

• Veno-occlusive disease (VOD) oder sinusoidales Obstruktionssyndrom. 
  Poetzsch ÜB, Bayraktar UDEditors: Madlener K, Poetzsch UB.Hämostaseologie, Springer-Verlag, Berlin

Abstracts/Posters

• A retrospective study of neoadjuvant DCF (docetaxel, cisplatin, 5-fluorouracil) for locally advanced gastric or gastroesophageal junction adenocarcinoma (GC).
  Castellanos R, Ernani V, Bayraktar UD, et al, J Clin Oncol
• Relevance and factors predicting for early lymphocyte recovery after allogeneic bone marrow stem cell transplantation (BMT).
  Bayraktar UD, Saliba RM, Rondon G, et al, Blood (ASH Annual Meeting Abstracts)
• Hematopoietic Cell Transplantation - Specific Comorbidity Index as an instrument to predict survival in patients admitted to intensive care unit early after allogeneic...
  Bayraktar UD, Shpall EJ, Liu P, et al, Blood (ASH Annual Meeting Abstracts)
• Ex-vivo T cell-depleted versus unmodified allografts in patients with acute myeloid leukemia in first complete remission: A comparison of outcomes in two institutions.
  Bayraktar UD, Shpall EJ, Liu P, et al, Blood (ASH Annual Meeting Abstracts)
• Improved early outcomes with T-cell replete (TCR) compared with T-cell depleted (TCD) haploidentical stem cell transplantation (HaploSCT).
  Ciurea SO, Saliba RM, Bayraktar UD, et al, Blood (ASH Annual Meeting Abstracts)
• Chromosome 7 abnormalities in allogeneic transplantation for AML and MDS.
  Kota V, Saliba RM, Bayraktar UD, et al, Blood (ASH Annual Meeting Abstracts)
• Outcome of patients with relapsed/refractory aids-related lymphoma.
  Noy A, Bayraktar UD, Gupta N, Moore P, Lensing S, Blood (ASH Annual Meeting Abstracts)
• The Use of High-Dose Azidothymidine Plus Methotrexate alone or in Combination with Conventional Chemotherapy is an Effective Approach.
  Bayraktar UD, Bernal E, Cabral L, et al, Infectious Agents and Cancer
• Primary CNS lymphoma in HIV-positive and -negative patients: Comparison of clinical characteristics, outcome, and prognostic factors.
  Bayraktar S, Bayraktar UD, Stefanovic A, Lossos IS, J Clin Oncol 28
• High-Dose Methotrexate and Azidothymidine in Combination with Alternating DA-EPOCH Is An Effective Regimen for the Treatment of EBV-Related Plasmablastic Lymphoma.
  Bayraktar UD, Ochoa R, Bayraktar S, Matsangou M, Ramos JC, Blood (ASH Annual Meeting Abstracts)
• Does delay of adjuvant chemotherapy affect the clinical outcome in patients with colon cancer?
  Bayraktar UD, Bayraktar S, Herna S, et al, J Clin Oncol 27
• Neoadjuvant dose-dense docetaxel, carboplatinum, and trastuzumab (ddTCH) chemotherapy for HER2 overexpressing breast cancer.
  Bayraktar S, Bayraktar UD, Reis IM, et al, J Clin Oncol 27
• An Unusual Presentation of Acute Biphenotypic Leukemia without Bone Marrow Involvement.
  Bayraktar UD, Escalon M, Blood (ASH Annual Meeting Abstracts)
• Catastrophic antiphospholipid syndrome (CAPS): comparison between CAPS patients with and without thrombocytopenia.
  Bayraktar UD, Erkan D, Asherson R, et al, Clin Exp Rheumatol
• Characteristics of patients with reflux esophagitis, non-erosive reflux disease, and functional heartburn.
  Seren S, Bayraktar UD, Ehrinpreis MN, Am J Gastroenterol
• Catastrophic antiphospholipid syndrome (CAPS): Poor prognostic factors for mortality.
  Bayraktar UD, Erkan D, Asherson R, et al, Arth Rheumat
• Catastrophic antiphospholipid syndrome (CAPS): Comparison between primary CAPS and lupus-associated CAPS.
  Bayraktar UD, Erkan D, Asherson R, et al, Arth Rheumat
• Desmoid tumor disguised as a pleural lesion.
  Theophyllus E, Bayraktar UD, Schmidt S, et al, Chest
• Join now to see all

Lectures

• Hematopoietic Cell Transplantation - Specific Comorbidity Index As An Instrument to Predict Survival in Patients Admitted to Intensive Care Unit Early After Allogeneic... 
  53rd ASH Annual Meeting and Exposition, San Diego, CA
• Tyrosine kinase inhibitors in the treatment of hepatocellular carcinoma. 
  International Association of Surgeons, Gastroenterologists, and Oncologists, Istanbul, Turkey
• Relevance and factors predicting for early lymphocyte recovery after allogeneic bone marrow stem cell transplantation. 
  54th ASH Annual Meeting and Exposition, Atlanta, GA
• Ex-Vivo T Cell-Depleted Versus Unmodified Allografts in Patients with Acute Myeloid Leukemia in First Complete Remission: A Comparison of Outcomes in Two Institutions. 
  53rd ASH Annual Meeting and Exposition, San Diego, CA
• Outcome of patients with relapsed/refractory aids-related lymphoma. 
  52nd ASH Annual Meeting and Exposition, Orlando, FL
• The Use of High-Dose Azidothymidine Plus Methotrexate alone or in Combination with Conventional Chemotherapy is an Effective Approach. 
  12th ICMAOI Meeting, Bethesda, MD
• Does delay of adjuvant chemotherapy affect the clinical outcome in patients with colon cancer? 
  ASCO 2009 Annual Meeting, Orlando, FL
• Precipitating Factors in Catastrophic Antiphospholipid Syndrome. 
  12th International Congress on Antiphospholipid Antibodies, Florence, Italy
• Catastrophic antiphospholipid syndrome (CAPS): comparison between CAPS patients with and without thrombocytopenia. 
  12th International Congress on Antiphospholipid Antibodies, Florence, Italy
• Catastrophic antiphospholipid syndrome (CAPS): Poor prognostic factors for mortality. 
  American College of Rheumatology Meeting, San Diego, CA
• Catastrophic antiphospholipid syndrome (CAPS): Comparison between primary CAPS and lupus-associated CAPS. 
  American College of Rheumatology Meeting, San Diego, CA
• Join now to see all

Other

• Successful treatment of anal gland adenocarcinoma with combined modality therapy. 
  Warsch S, Bayraktar UD, Wen B, Zeitouni J, Marchetti F, Rocha-Lima CM, Montero AJ
• Outcome of patients with relapsed/refractory AIDS-related lymphoma diagnosed 1999-2008 and treated with curative intent in the AIDS malignancy consortium. 
  Bayraktar UD, Ramos JC, Petrich A, et al
• Vitamin D receptor upregulation in alloreactive human T cells. 
  Joseph RW, Bayraktar UD, Kim TK, et al
• Treatment of FLT3-ITD-positive acute myeloid leukemia relapsing after allogeneic stem cell transplantation with sorafenib. 
  Sharma M, Ravandi F, Bayraktar UD, et al
• High dose glucocorticoids improve renal failure reversibility in patients with newly diagnosed multiple myeloma. 
  Bayraktar UD, Warsch S, Pereira D
• Primary ocular adnexal MALT lymphoma: Single institution experience in a large cohort of patients. 
  Bayraktar S, Bayraktar UD, Stefanovic A, Lossos IS
• The clinical spectrum of catastrophic antiphospholipid syndrome in the presence or absence of lupus. 
  Bayraktar UD, Erkan D, Bucciarelli S, et al
• Determining domestic formaldehyde levels in Ankara, Turkey. 
  Vaizoglu SA, Aycan S, Deveci MA, Acer T, Bulut B, Bayraktar UD, Akyollu B, Celik M, Arslan U, Akpinar F, Baris Z, Arslan S, Deniz A, Evci ED, Guler C
• Hepatic Venous Outflow Obstruction. 
  Bayraktar UD, Seren S, Bayraktar Y
• Join now to see all